Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type: 2018 VS 2023 VS 2033
1.2.2 High-throughput Sequencing
1.2.3 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
1.2.4 Immunological Detection
1.3 Market by Application
1.3.1 Global COVID-19 Molecular Diagnostics Market Growth by Application: 2018 VS 2023 VS 2033
1.3.2 Hospitals
1.3.3 Scientific Research
1.3.4 Biodiagnostics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global COVID-19 Molecular Diagnostics Market Perspective (2018-2033)
2.2 COVID-19 Molecular Diagnostics Growth Trends by Region
2.2.1 Global COVID-19 Molecular Diagnostics Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 COVID-19 Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 COVID-19 Molecular Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 COVID-19 Molecular Diagnostics Market Dynamics
2.3.1 COVID-19 Molecular Diagnostics Industry Trends
2.3.2 COVID-19 Molecular Diagnostics Market Drivers
2.3.3 COVID-19 Molecular Diagnostics Market Challenges
2.3.4 COVID-19 Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top COVID-19 Molecular Diagnostics Players by Revenue
3.1.1 Global Top COVID-19 Molecular Diagnostics Players by Revenue (2018-2023)
3.1.2 Global COVID-19 Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global COVID-19 Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by COVID-19 Molecular Diagnostics Revenue
3.4 Global COVID-19 Molecular Diagnostics Market Concentration Ratio
3.4.1 Global COVID-19 Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COVID-19 Molecular Diagnostics Revenue in 2023
3.5 COVID-19 Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players COVID-19 Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into COVID-19 Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COVID-19 Molecular Diagnostics Breakdown Data by Type
4.1 Global COVID-19 Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global COVID-19 Molecular Diagnostics Forecasted Market Size by Type (2024-2033)
5 COVID-19 Molecular Diagnostics Breakdown Data by Application
5.1 Global COVID-19 Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global COVID-19 Molecular Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America COVID-19 Molecular Diagnostics Market Size (2018-2033)
6.2 North America COVID-19 Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2023 VS 2033
6.3 North America COVID-19 Molecular Diagnostics Market Size by Country (2018-2023)
6.4 North America COVID-19 Molecular Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe COVID-19 Molecular Diagnostics Market Size (2018-2033)
7.2 Europe COVID-19 Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2023 VS 2033
7.3 Europe COVID-19 Molecular Diagnostics Market Size by Country (2018-2023)
7.4 Europe COVID-19 Molecular Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific COVID-19 Molecular Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific COVID-19 Molecular Diagnostics Market Growth Rate by Region: 2018 VS 2023 VS 2033
8.3 Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America COVID-19 Molecular Diagnostics Market Size (2018-2033)
9.2 Latin America COVID-19 Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2023 VS 2033
9.3 Latin America COVID-19 Molecular Diagnostics Market Size by Country (2018-2023)
9.4 Latin America COVID-19 Molecular Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa COVID-19 Molecular Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa COVID-19 Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2023 VS 2033
10.3 Middle East & Africa COVID-19 Molecular Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa COVID-19 Molecular Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellex
11.1.1 Cellex Company Detail
11.1.2 Cellex Business Overview
11.1.3 Cellex COVID-19 Molecular Diagnostics Introduction
11.1.4 Cellex Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.1.5 Cellex Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott COVID-19 Molecular Diagnostics Introduction
11.2.4 Abbott Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche COVID-19 Molecular Diagnostics Introduction
11.3.4 Roche Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.3.5 Roche Recent Development
11.4 BioMedomics
11.4.1 BioMedomics Company Detail
11.4.2 BioMedomics Business Overview
11.4.3 BioMedomics COVID-19 Molecular Diagnostics Introduction
11.4.4 BioMedomics Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.4.5 BioMedomics Recent Development
11.5 BD
11.5.1 BD Company Detail
11.5.2 BD Business Overview
11.5.3 BD COVID-19 Molecular Diagnostics Introduction
11.5.4 BD Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.5.5 BD Recent Development
11.6 Henry Schein
11.6.1 Henry Schein Company Detail
11.6.2 Henry Schein Business Overview
11.6.3 Henry Schein COVID-19 Molecular Diagnostics Introduction
11.6.4 Henry Schein Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.6.5 Henry Schein Recent Development
11.7 Safecare Bio-Tech
11.7.1 Safecare Bio-Tech Company Detail
11.7.2 Safecare Bio-Tech Business Overview
11.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Introduction
11.7.4 Safecare Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.7.5 Safecare Bio-Tech Recent Development
11.8 Thermo Fisher
11.8.1 Thermo Fisher Company Detail
11.8.2 Thermo Fisher Business Overview
11.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Introduction
11.8.4 Thermo Fisher Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.8.5 Thermo Fisher Recent Development
11.9 Bio-rad
11.9.1 Bio-rad Company Detail
11.9.2 Bio-rad Business Overview
11.9.3 Bio-rad COVID-19 Molecular Diagnostics Introduction
11.9.4 Bio-rad Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.9.5 Bio-rad Recent Development
11.10 Agilent
11.10.1 Agilent Company Detail
11.10.2 Agilent Business Overview
11.10.3 Agilent COVID-19 Molecular Diagnostics Introduction
11.10.4 Agilent Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.10.5 Agilent Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Detail
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 Zhejiang Orient Gene Biotech
11.12.1 Zhejiang Orient Gene Biotech Company Detail
11.12.2 Zhejiang Orient Gene Biotech Business Overview
11.12.3 Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Introduction
11.12.4 Zhejiang Orient Gene Biotech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.12.5 Zhejiang Orient Gene Biotech Recent Development
11.13 Innovita Biological Technology
11.13.1 Innovita Biological Technology Company Detail
11.13.2 Innovita Biological Technology Business Overview
11.13.3 Innovita Biological Technology COVID-19 Molecular Diagnostics Introduction
11.13.4 Innovita Biological Technology Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.13.5 Innovita Biological Technology Recent Development
11.14 Guangzhou Wondfo Biotech
11.14.1 Guangzhou Wondfo Biotech Company Detail
11.14.2 Guangzhou Wondfo Biotech Business Overview
11.14.3 Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Introduction
11.14.4 Guangzhou Wondfo Biotech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.14.5 Guangzhou Wondfo Biotech Recent Development
11.15 Guangdong Hecin-Scientific
11.15.1 Guangdong Hecin-Scientific Company Detail
11.15.2 Guangdong Hecin-Scientific Business Overview
11.15.3 Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Introduction
11.15.4 Guangdong Hecin-Scientific Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.15.5 Guangdong Hecin-Scientific Recent Development
11.16 Dynamiker Biotechnology (Tianjin)
11.16.1 Dynamiker Biotechnology (Tianjin) Company Detail
11.16.2 Dynamiker Biotechnology (Tianjin) Business Overview
11.16.3 Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Introduction
11.16.4 Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.16.5 Dynamiker Biotechnology (Tianjin) Recent Development
11.17 ADVAITE
11.17.1 ADVAITE Company Detail
11.17.2 ADVAITE Business Overview
11.17.3 ADVAITE COVID-19 Molecular Diagnostics Introduction
11.17.4 ADVAITE Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.17.5 ADVAITE Recent Development
11.18 Mayo Clinic Laboratories
11.18.1 Mayo Clinic Laboratories Company Detail
11.18.2 Mayo Clinic Laboratories Business Overview
11.18.3 Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Introduction
11.18.4 Mayo Clinic Laboratories Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.18.5 Mayo Clinic Laboratories Recent Development
11.19 Chembio Diagnostics
11.19.1 Chembio Diagnostics Company Detail
11.19.2 Chembio Diagnostics Business Overview
11.19.3 Chembio Diagnostics COVID-19 Molecular Diagnostics Introduction
11.19.4 Chembio Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.19.5 Chembio Diagnostics Recent Development
11.20 Mount Sinai Laboratory
11.20.1 Mount Sinai Laboratory Company Detail
11.20.2 Mount Sinai Laboratory Business Overview
11.20.3 Mount Sinai Laboratory COVID-19 Molecular Diagnostics Introduction
11.20.4 Mount Sinai Laboratory Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.20.5 Mount Sinai Laboratory Recent Development
11.21 QIAGEN
11.21.1 QIAGEN Company Detail
11.21.2 QIAGEN Business Overview
11.21.3 QIAGEN COVID-19 Molecular Diagnostics Introduction
11.21.4 QIAGEN Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.21.5 QIAGEN Recent Development
11.22 Bioer
11.22.1 Bioer Company Detail
11.22.2 Bioer Business Overview
11.22.3 Bioer COVID-19 Molecular Diagnostics Introduction
11.22.4 Bioer Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.22.5 Bioer Recent Development
11.23 Biosynex
11.23.1 Biosynex Company Detail
11.23.2 Biosynex Business Overview
11.23.3 Biosynex COVID-19 Molecular Diagnostics Introduction
11.23.4 Biosynex Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.23.5 Biosynex Recent Development
11.24 Esco
11.24.1 Esco Company Detail
11.24.2 Esco Business Overview
11.24.3 Esco COVID-19 Molecular Diagnostics Introduction
11.24.4 Esco Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.24.5 Esco Recent Development
11.25 Analytik Jena
11.25.1 Analytik Jena Company Detail
11.25.2 Analytik Jena Business Overview
11.25.3 Analytik Jena COVID-19 Molecular Diagnostics Introduction
11.25.4 Analytik Jena Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.25.5 Analytik Jena Recent Development
11.26 Techne
11.26.1 Techne Company Detail
11.26.2 Techne Business Overview
11.26.3 Techne COVID-19 Molecular Diagnostics Introduction
11.26.4 Techne Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.26.5 Techne Recent Development
11.27 Da An Gene
11.27.1 Da An Gene Company Detail
11.27.2 Da An Gene Business Overview
11.27.3 Da An Gene COVID-19 Molecular Diagnostics Introduction
11.27.4 Da An Gene Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.27.5 Da An Gene Recent Development
11.28 BGI
11.28.1 BGI Company Detail
11.28.2 BGI Business Overview
11.28.3 BGI COVID-19 Molecular Diagnostics Introduction
11.28.4 BGI Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.28.5 BGI Recent Development
11.29 Shanghai ZJ Bio-Tech
11.29.1 Shanghai ZJ Bio-Tech Company Detail
11.29.2 Shanghai ZJ Bio-Tech Business Overview
11.29.3 Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Introduction
11.29.4 Shanghai ZJ Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023)
11.29.5 Shanghai ZJ Bio-Tech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2023 VS 2033
Table 2. Key Players of High-throughput Sequencing
Table 3. Key Players of Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Table 4. Key Players of Immunological Detection
Table 5. Global COVID-19 Molecular Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2023 VS 2033
Table 6. Global COVID-19 Molecular Diagnostics Market Size by Region (US$ Million): 2018 VS 2023 VS 2033
Table 7. Global COVID-19 Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global COVID-19 Molecular Diagnostics Market Share by Region (2018-2023)
Table 9. Global COVID-19 Molecular Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global COVID-19 Molecular Diagnostics Market Share by Region (2024-2033)
Table 11. COVID-19 Molecular Diagnostics Market Trends
Table 12. COVID-19 Molecular Diagnostics Market Drivers
Table 13. COVID-19 Molecular Diagnostics Market Challenges
Table 14. COVID-19 Molecular Diagnostics Market Restraints
Table 15. Global COVID-19 Molecular Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global COVID-19 Molecular Diagnostics Market Share by Players (2018-2023)
Table 17. Global Top COVID-19 Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Molecular Diagnostics as of 2023)
Table 18. Ranking of Global Top COVID-19 Molecular Diagnostics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by COVID-19 Molecular Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players COVID-19 Molecular Diagnostics Product Solution and Service
Table 22. Date of Enter into COVID-19 Molecular Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global COVID-19 Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global COVID-19 Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 26. Global COVID-19 Molecular Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global COVID-19 Molecular Diagnostics Revenue Market Share by Type (2024-2033)
Table 28. Global COVID-19 Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global COVID-19 Molecular Diagnostics Revenue Market Share by Application (2018-2023)
Table 30. Global COVID-19 Molecular Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global COVID-19 Molecular Diagnostics Revenue Market Share by Application (2024-2033)
Table 32. North America COVID-19 Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 33. North America COVID-19 Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America COVID-19 Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe COVID-19 Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 36. Europe COVID-19 Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe COVID-19 Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific COVID-19 Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2023 VS 2033
Table 39. Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific COVID-19 Molecular Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America COVID-19 Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 42. Latin America COVID-19 Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America COVID-19 Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa COVID-19 Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2023 VS 2033
Table 45. Middle East & Africa COVID-19 Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa COVID-19 Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 47. Cellex Company Detail
Table 48. Cellex Business Overview
Table 49. Cellex COVID-19 Molecular Diagnostics Product
Table 50. Cellex Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 51. Cellex Recent Development
Table 52. Abbott Company Detail
Table 53. Abbott Business Overview
Table 54. Abbott COVID-19 Molecular Diagnostics Product
Table 55. Abbott Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 56. Abbott Recent Development
Table 57. Roche Company Detail
Table 58. Roche Business Overview
Table 59. Roche COVID-19 Molecular Diagnostics Product
Table 60. Roche Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 61. Roche Recent Development
Table 62. BioMedomics Company Detail
Table 63. BioMedomics Business Overview
Table 64. BioMedomics COVID-19 Molecular Diagnostics Product
Table 65. BioMedomics Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 66. BioMedomics Recent Development
Table 67. BD Company Detail
Table 68. BD Business Overview
Table 69. BD COVID-19 Molecular Diagnostics Product
Table 70. BD Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 71. BD Recent Development
Table 72. Henry Schein Company Detail
Table 73. Henry Schein Business Overview
Table 74. Henry Schein COVID-19 Molecular Diagnostics Product
Table 75. Henry Schein Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 76. Henry Schein Recent Development
Table 77. Safecare Bio-Tech Company Detail
Table 78. Safecare Bio-Tech Business Overview
Table 79. Safecare Bio-Tech COVID-19 Molecular Diagnostics Product
Table 80. Safecare Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 81. Safecare Bio-Tech Recent Development
Table 82. Thermo Fisher Company Detail
Table 83. Thermo Fisher Business Overview
Table 84. Thermo Fisher COVID-19 Molecular Diagnostics Product
Table 85. Thermo Fisher Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 86. Thermo Fisher Recent Development
Table 87. Bio-rad Company Detail
Table 88. Bio-rad Business Overview
Table 89. Bio-rad COVID-19 Molecular Diagnostics Product
Table 90. Bio-rad Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 91. Bio-rad Recent Development
Table 92. Agilent Company Detail
Table 93. Agilent Business Overview
Table 94. Agilent COVID-19 Molecular Diagnostics Product
Table 95. Agilent Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 96. Agilent Recent Development
Table 97. Ortho Clinical Diagnostics Company Detail
Table 98. Ortho Clinical Diagnostics Business Overview
Table 99. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Product
Table 100. Ortho Clinical Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 101. Ortho Clinical Diagnostics Recent Development
Table 102. Zhejiang Orient Gene Biotech Company Detail
Table 103. Zhejiang Orient Gene Biotech Business Overview
Table 104. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Product
Table 105. Zhejiang Orient Gene Biotech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 106. Zhejiang Orient Gene Biotech Recent Development
Table 107. Innovita Biological Technology Company Detail
Table 108. Innovita Biological Technology Business Overview
Table 109. Innovita Biological Technology COVID-19 Molecular Diagnostics Product
Table 110. Innovita Biological Technology Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 111. Innovita Biological Technology Recent Development
Table 112. Guangzhou Wondfo Biotech Company Detail
Table 113. Guangzhou Wondfo Biotech Business Overview
Table 114. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Product
Table 115. Guangzhou Wondfo Biotech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 116. Guangzhou Wondfo Biotech Recent Development
Table 117. Guangdong Hecin-Scientific Company Detail
Table 118. Guangdong Hecin-Scientific Business Overview
Table 119. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Product
Table 120. Guangdong Hecin-Scientific Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 121. Guangdong Hecin-Scientific Recent Development
Table 122. Dynamiker Biotechnology (Tianjin) Company Detail
Table 123. Dynamiker Biotechnology (Tianjin) Business Overview
Table 124. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Product
Table 125. Dynamiker Biotechnology (Tianjin) Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 126. Dynamiker Biotechnology (Tianjin) Recent Development
Table 127. ADVAITE Company Detail
Table 128. ADVAITE Business Overview
Table 129. ADVAITE COVID-19 Molecular Diagnostics Product
Table 130. ADVAITE Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 131. ADVAITE Recent Development
Table 132. Mayo Clinic Laboratories Company Detail
Table 133. Mayo Clinic Laboratories Business Overview
Table 134. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Product
Table 135. Mayo Clinic Laboratories Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 136. Mayo Clinic Laboratories Recent Development
Table 137. Chembio Diagnostics Company Detail
Table 138. Chembio Diagnostics Business Overview
Table 139. Chembio Diagnostics COVID-19 Molecular Diagnostics Product
Table 140. Chembio Diagnostics Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 141. Chembio Diagnostics Recent Development
Table 142. Mount Sinai Laboratory Company Detail
Table 143. Mount Sinai Laboratory Business Overview
Table 144. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Product
Table 145. Mount Sinai Laboratory Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 146. Mount Sinai Laboratory Recent Development
Table 147. QIAGEN Company Detail
Table 148. QIAGEN Business Overview
Table 149. QIAGEN COVID-19 Molecular Diagnostics Product
Table 150. QIAGEN Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 151. QIAGEN Recent Development
Table 152. Bioer Company Detail
Table 153. Bioer Business Overview
Table 154. Bioer COVID-19 Molecular Diagnostics Product
Table 155. Bioer Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 156. Bioer Recent Development
Table 157. Biosynex Company Detail
Table 158. Biosynex Business Overview
Table 159. Biosynex COVID-19 Molecular Diagnostics Product
Table 160. Biosynex Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 161. Biosynex Recent Development
Table 162. Esco Company Detail
Table 163. Esco Business Overview
Table 164. Esco COVID-19 Molecular Diagnostics Product
Table 165. Esco Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 166. Esco Recent Development
Table 167. Analytik Jena Company Detail
Table 168. Analytik Jena Business Overview
Table 169. Analytik Jena COVID-19 Molecular Diagnostics Product
Table 170. Analytik Jena Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 171. Analytik Jena Recent Development
Table 172. Techne Company Detail
Table 173. Techne Business Overview
Table 174. Techne COVID-19 Molecular Diagnostics Product
Table 175. Techne Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 176. Techne Recent Development
Table 177. Da An Gene Company Detail
Table 178. Da An Gene Business Overview
Table 179. Da An Gene COVID-19 Molecular Diagnostics Product
Table 180. Da An Gene Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 181. Da An Gene Recent Development
Table 182. BGI Company Detail
Table 183. BGI Business Overview
Table 184. BGI COVID-19 Molecular Diagnostics Product
Table 185. BGI Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 186. BGI Recent Development
Table 187. Shanghai ZJ Bio-Tech Company Detail
Table 188. Shanghai ZJ Bio-Tech Business Overview
Table 189. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Product
Table 190. Shanghai ZJ Bio-Tech Revenue in COVID-19 Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 191. Shanghai ZJ Bio-Tech Recent Development
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 Molecular Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global COVID-19 Molecular Diagnostics Market Share by Type: 2023 VS 2033
Figure 3. High-throughput Sequencing Features
Figure 4. Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Features
Figure 5. Immunological Detection Features
Figure 6. Global COVID-19 Molecular Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global COVID-19 Molecular Diagnostics Market Share by Application: 2023 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Scientific Research Case Studies
Figure 10. Biodiagnostics Case Studies
Figure 11. COVID-19 Molecular Diagnostics Report Years Considered
Figure 12. Global COVID-19 Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global COVID-19 Molecular Diagnostics Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 14. Global COVID-19 Molecular Diagnostics Market Share by Region: 2023 VS 2033
Figure 15. Global COVID-19 Molecular Diagnostics Market Share by Players in 2023
Figure 16. Global Top COVID-19 Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Molecular Diagnostics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by COVID-19 Molecular Diagnostics Revenue in 2023
Figure 18. North America COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America COVID-19 Molecular Diagnostics Market Share by Country (2018-2033)
Figure 20. United States COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe COVID-19 Molecular Diagnostics Market Share by Country (2018-2033)
Figure 24. Germany COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific COVID-19 Molecular Diagnostics Market Share by Region (2018-2033)
Figure 32. China COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America COVID-19 Molecular Diagnostics Market Share by Country (2018-2033)
Figure 40. Mexico COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa COVID-19 Molecular Diagnostics Market Share by Country (2018-2033)
Figure 44. Turkey COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia COVID-19 Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Cellex Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 47. Abbott Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 48. Roche Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 49. BioMedomics Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 50. BD Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 51. Henry Schein Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 52. Safecare Bio-Tech Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 53. Thermo Fisher Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 54. Bio-rad Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 55. Agilent Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 56. Ortho Clinical Diagnostics Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 57. Zhejiang Orient Gene Biotech Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 58. Innovita Biological Technology Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 59. Guangzhou Wondfo Biotech Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 60. Guangdong Hecin-Scientific Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 61. Dynamiker Biotechnology (Tianjin) Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 62. ADVAITE Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 63. Mayo Clinic Laboratories Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 64. Chembio Diagnostics Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 65. Mount Sinai Laboratory Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 66. QIAGEN Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 67. Bioer Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 68. Biosynex Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 69. Esco Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 70. Analytik Jena Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 71. Techne Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 72. Da An Gene Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 73. BGI Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 74. Shanghai ZJ Bio-Tech Revenue Growth Rate in COVID-19 Molecular Diagnostics Business (2018-2023)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed